Evox Therapeutics

Transformative Exosome Therapeutics

Oxford, United Kingdom · Founded 2016 · $153.8M raised

Headquarters
Oxford
Employees
51–200
Founded
2016
Business Model
B2B
Total Funding
$153.8M
Last Round
$95.4M Series CFeb 2021
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 5 investors for this company. The full record is or through the API.

About

Evox Therapeutics is a science-driven biotechnology company addressing genetically driven neurodegenerative diseases with next-generation genome editing delivered by exosomes. Its proprietary pipeline is led by an MSH3 program for Huntington’s disease, with additional ATXN2 programs for ALS and SCA2, and broader work across genetic and non-genetic central nervous system diseases. Through the ExoEdit platform, Evox combines CRISPR-Cas editors with the natural targeting and delivery capabilities of exosomes so genetic medicines can reach the brain rather than remaining liver-centric. The company is rooted in research from the University of Oxford and the Karolinska Institute.

Summary

Evox Therapeutics is a Biotech company based in Oxford, United Kingdom, founded in 2016. It has raised $153.8M in total across 3 rounds, most recently a $95.4M Series C round in Feb 2021. Investors include Redmile Group, Oxford Science Enterprises and GV.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CFeb 2021
$95.4M

Sign up to see all 3 events

Funding: Seed through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Evox Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/evox-therapeutics"><img src="https://indexed.vc/api/badge/company/evox-therapeutics" alt="Evox Therapeutics on Indexed.vc" width="260" height="76" /></a>